These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35262977)

  • 21. Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs: review of the literature.
    Wilke M
    Eur J Med Res; 2011 Apr; 16(4):180-6. PubMed ID: 21486732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of micafungin for invasive candida infections: a meta-analysis of randomized controlled trials.
    Chen Q; Lin MH; Chen ML; Liu ZY; Chai D; Wang R
    Chin Med J (Engl); 2012 Jan; 125(2):345-51. PubMed ID: 22340571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
    Sohn HS; Lee TJ; Kim J; Kim D
    Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Candida norvegensis fungemia in a liver transplant recipient.
    Sanclemente G; Marco F; Cervera C; Hoyo I; Colmenero J; Pitart C; Almela M; Navasa M; Moreno A
    Rev Iberoam Micol; 2015; 32(2):115-7. PubMed ID: 24794213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study.
    Zilberberg M; Yu HT; Chaudhari P; Emons MF; Khandelwal N; Shorr AF
    Crit Care; 2014 Oct; 18(5):590. PubMed ID: 25358521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifungal susceptibility, species distribution and risk factors associated with mortality of invasive candidiasis in children in Turkey: A six-year retrospective, single-centre study.
    Yakut N; Kepenekli E; Ergenc Z; Baran E; Cerikcioglu N
    J Mycol Med; 2021 Mar; 31(1):101082. PubMed ID: 33249314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
    Cornely OA; Vazquez J; De Waele J; Betts R; Rotstein C; Nucci M; Pappas PG; Ullmann AJ
    Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution.
    Liew YX; Teo J; Too IA; Ngan CC; Tan AL; Chlebicki MP; Kwa AL; Lee W
    BMC Infect Dis; 2015 Jul; 15():256. PubMed ID: 26137997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.
    Pfaller MA; Andes DR; Diekema DJ; Horn DL; Reboli AC; Rotstein C; Franks B; Azie NE
    PLoS One; 2014; 9(7):e101510. PubMed ID: 24991967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.
    Lepak AJ; Zhao M; Berkow EL; Lockhart SR; Andes DR
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584152
    [No Abstract]   [Full Text] [Related]  

  • 32. [Scientific evidence supporting the use of micafungin in the treatment of invasive candidiasis].
    Montejo M; Quindós G
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():15-22. PubMed ID: 21420572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of new antifungal agents in prophylaxis of mycoses in high risk patients.
    van Burik JA
    Curr Opin Infect Dis; 2005 Dec; 18(6):479-83. PubMed ID: 16258319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluconazole prophylaxis for prevention of invasive candidiasis in infants.
    Ericson JE; Benjamin DK
    Curr Opin Pediatr; 2014 Apr; 26(2):151-6. PubMed ID: 24626156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Micafungin: A Review in the Prophylaxis and Treatment of Invasive Candida Infections in Paediatric Patients.
    Scott LJ
    Paediatr Drugs; 2017 Feb; 19(1):81-90. PubMed ID: 28083856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. The Canadian Fluconazole Study.
    Laverdière M; Rotstein C; Bow EJ; Roberts RS; Ioannou S; Carr D; Moghaddam N
    J Antimicrob Chemother; 2000 Dec; 46(6):1001-8. PubMed ID: 11102422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropenia.
    Chandrasekar P; Sirohi B; Seibel NL; Hsu JW; Azie N; Wu C; Ruhnke M
    Mycoses; 2018 May; 61(5):331-336. PubMed ID: 29364548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients.
    van Burik JH; Leisenring W; Myerson D; Hackman RC; Shulman HM; Sale GE; Bowden RA; McDonald GB
    Medicine (Baltimore); 1998 Jul; 77(4):246-54. PubMed ID: 9715729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of susceptibility patterns using commercially available susceptibility testing methods performed on prevalent Candida spp.
    Cretella D; Barber KE; King ST; Stover KR
    J Med Microbiol; 2016 Dec; 65(12):1445-1451. PubMed ID: 27902377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates.
    Steinbach WJ; Roilides E; Berman D; Hoffman JA; Groll AH; Bin-Hussain I; Palazzi DL; Castagnola E; Halasa N; Velegraki A; Dvorak CC; Charkabarti A; Sung L; Danziger-Isakov L; Lachenauer C; Arrieta A; Knapp K; Abzug MJ; Ziebold C; Lehrnbecher T; Klingspor L; Warris A; Leckerman K; Martling T; Walsh TJ; Benjamin DK; Zaoutis TE;
    Pediatr Infect Dis J; 2012 Dec; 31(12):1252-7. PubMed ID: 22982980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.